Burzykowski, T; Carpenter, J; Coens, C; Evans, D; France, L; Kenward, M; Lane, P; Matcham, J; Morgan, D; Phillips, A; +4 more... Roger, J; Sullivan, B; White, I; Yu, LM; (2010) Missing data: Discussion points from the PSI missing data expert group. Pharmaceutical statistics, 9 (4). pp. 288-297. ISSN 1539-1604 DOI: https://doi.org/10.1002/pst.391 Full text not available from this repository.

Fletcher, C; Chuang-Stein, C; Paget, MA; Reid, C; Hawkins, N; (2014) Subgroup analyses in cost-effectiveness analyses to support health technology assessments. Pharmaceutical statistics, 13 (4). pp. 265-74. ISSN 1539-1604 DOI: https://doi.org/10.1002/pst.1626 Full text not available from this repository.

Lamb, KE; Williamson, EJ; Coory, M; Carlin, JB; (2015) Bias and precision of measures of survival gain from right-censored data. Pharmaceutical statistics. ISSN 1539-1604 DOI: https://doi.org/10.1002/pst.1700 Full text not available from this repository.

Ng, ES; Klungel, OH; Groenwold, RH; van Staa, TP; (2015) Risk patterns in drug safety study using relative times by accelerated failure time models when proportional hazards assumption is questionable: an illustrative case study of cancer risk of patients on glucose-lowering therapies. Pharmaceutical statistics. ISSN 1539-1604 DOI: https://doi.org/10.1002/pst.1697 Full text not available from this repository.

Phillips, A; Abellan-Andres, J; Soren, A; Bretz, F; Fletcher, C; France, L; Garrett, A; Harris, R; Kjaer, M; Keene, O; +3 more... Morgan, D; O'Kelly, M; Roger, J; (2016) Estimands: discussion points from the PSI estimands and sensitivity expert group. Pharmaceutical statistics, 16 (1). pp. 6-11. ISSN 1539-1604 DOI: https://doi.org/10.1002/pst.1745 Full text not available from this repository.

Prieto-Merino, D; Quartey, G; Wang, J; Kim, J; (2011) Why a Bayesian approach to safety analysis in pharmacovigilance is important. Pharmaceutical statistics, 10 (6). pp. 554-9. ISSN 1539-1604 DOI: https://doi.org/10.1002/pst.524 Full text not available from this repository.

Quartey, G; Feudjo-Tepie, M; Wang, J; Kim, J; (2011) Opportunities for minimization of confounding in observational research. Pharmaceutical statistics, 10 (6). pp. 539-47. ISSN 1539-1604 DOI: https://doi.org/10.1002/pst.528 Full text not available from this repository.

Reddy, T; Molenberghs, G; Njagi, EN; Aerts, M; (2016) A novel approach to estimation of the time to biomarker threshold: applications to HIV. Pharmaceutical statistics, 15 (6). pp. 541-549. ISSN 1539-1604 DOI: https://doi.org/10.1002/pst.1774 Full text not available from this repository.

Wang, D; Pocock, S; (2016) A win ratio approach to comparing continuous non-normal outcomes in clinical trials. Pharmaceutical statistics, 15 (3). pp. 238-45. ISSN 1539-1604 DOI: https://doi.org/10.1002/pst.1743 Full text not available from this repository.

Burzykowski, T; Carpenter, J; Coens, C; Evans, D; France, L; Kenward, M; Lane, P; Matcham, J; Morgan, D; Phillips, A; +4 more... Roger, J; Sullivan, B; White, I; Yu, LM; (2009) Missing data: Discussion points from the PSI missing data expert group. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/2460 Full text not available from this repository.